EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Potential of Apigenin, Berberine, Chrysin, and Luteolin to Overcome Doxorubicin Resistance in Acute Promyelocytic Leukemia HL-60 Cells

Piotr Wadowski iD, Katarzyna Woźniak iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262110565 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Piotr Wadowski und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland. Hauptthemen laut MEDLINE: Luteolin, Apigenin, Berberine, Doxorubicin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multidrug resistance (MDR) is one of the leading causes of high mortality in cancer. The NRF2 (Nuclear Factor Erythroid 2-Related Factor 2) transcriptional factor can play a major role in MDR development. In this study, we tested the NRF2 inhibitors—Apigenin, Berberine, Chrysin, and Luteolin (ABCL) for their ability to overcome doxorubicin resistance in acute promyelocytic leukemia HL-60 cells (HL-60/DOXO cells). We examined the effects of NRF2 inhibitors on cell viability, apoptosis, DNA damage, and reactive oxygen species (ROS) generation. Our results indicate that Apigenin, Chrysin, and Luteolin can effectively overcome doxorubicin resistance in HL-60/DOXO cells. On the contrary, Berberine does not demonstrate this activity and even hinders doxorubicin’s activity. We hypothesize that the observed effects of ABCL may result from their interaction with the NRF2 factor, which is hyperactivated in the tested HL-60/DOXO cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LuteolinApigeninBerberineDoxorubicinLeukemia, Promyelocytic, AcuteDrug Resistance, NeoplasmFlavonoidsHumansHL-60 CellsNF-E2-Related Factor 2Reactive Oxygen SpeciesApoptosisCell SurvivalDNA Damage

Stichwörter der Autor:innen

ApigeninBerberineChrysinHL-60 cellsLuteolinNRF2 inhibitorsdoxorubicinresistance

Substanzen

LuteolinApigeninBerberineDoxorubicinNF-E2-Related Factor 2chrysinFlavonoidsReactive Oxygen SpeciesNFE2L2 protein, human

Autor:innen und Institutionen

  • Department of Molecular Genetics, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland.
  • Doctoral School of Exact and Natural Sciences, University of Lodz, Banacha 12/16, 90-237 Lodz, Poland.

ORCID-Profile: Piotr Wadowski, Katarzyna Woźniak

Zitieren

APA

Wadowski, P., & Woźniak, K. (2025). Potential of Apigenin, Berberine, Chrysin, and Luteolin to Overcome Doxorubicin Resistance in Acute Promyelocytic Leukemia HL-60 Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110565

Vancouver

Wadowski P, Woźniak K. Potential of Apigenin, Berberine, Chrysin, and Luteolin to Overcome Doxorubicin Resistance in Acute Promyelocytic Leukemia HL-60 Cells. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110565

BibTeX
@article{Wadowski2025,
  author = {Wadowski, Piotr and Woźniak, Katarzyna},
  title = {Potential of Apigenin, Berberine, Chrysin, and Luteolin to Overcome Doxorubicin Resistance in Acute Promyelocytic Leukemia HL-60 Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262110565}
}
Kostenlos starten →